• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Further increase in forearm cortical bone mineral content after discontinuation of growth hormone replacement.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Holmes, Sarah J
    Whitehouse, Richard W
    Economou, Georgia
    O'Halloran, Domhnall J
    Adams, Judith E
    Shalet, Stephen M
    Affiliation
    Department of Endocrinology, Christie Hospital NHS Trust, Manchester, UK.
    Issue Date
    1995-01
    
    Metadata
    Show full item record
    Abstract
    OBJECTIVE: Growth hormone replacement of adults with childhood onset GH deficiency results in an increase in bone mineral density (BMD) after 6-12 months of GH replacement. By measuring BMD 12 months after discontinuation of GH replacement we aimed to investigate whether there is an effect of GH replacement on BMD persisting after GH has been withdrawn. DESIGN: BMD was measured 13 +/- 1 (mean +/- SE, range 11-16) months after discontinuation of GH replacement. PATIENTS: Ten adults, age 23.2 +/- 1.4 (range 18.8-32.4) years, with childhood onset isolated GH deficiency (2 idiopathic, 8 irradiation induced) who had previously completed a study of the effect of 12 months of GH replacement on BMD. MEASUREMENTS: Forearm cortical bone mineral content (BMC) was measured using single-photon absorptiometry at the proximal site of the distal forearm. Forearm integral BMC at the ultradistal site of the forearm and bone width at both proximal and ultradistal sites of the distal forearm were measured by the same technique. Vertebral trabecular BMD was measured using quantitative computed tomography. RESULTS: Forearm cortical BMC was significantly greater than that measured at the time of discontinuation of GH (1.48 +/- 0.04 vs 1.44 +/- 0.05 g/cm). There was no significant change in forearm integral BMC or in vertebral trabecular BMD after discontinuation of GH. There was no significant change in bone width at proximal and ultradistal sites of the distal forearm after discontinuation of GH. CONCLUSION: After discontinuation of GH replacement the further increase in forearm cortical bone mineral content without a significant increase in forearm bone width suggests that the increase in cortical bone mineral content is due to a persisting effect of previous GH replacement, and not to further spontaneous attainment of bone mass before peak bone mass is reached. These findings emphasize the importance of continuing to monitor bone mass after the stimulus to increase bone turnover has been withdrawn.
    Citation
    Further increase in forearm cortical bone mineral content after discontinuation of growth hormone replacement. 1995, 42 (1):3-7 Clin. Endocrinol
    Journal
    Clinical Endocrinology
    URI
    http://hdl.handle.net/10541/98402
    DOI
    10.1111/j.1365-2265.1995.tb02591.x
    PubMed ID
    7889628
    Type
    Article
    Language
    en
    ISSN
    0300-0664
    ae974a485f413a2113503eed53cd6c53
    10.1111/j.1365-2265.1995.tb02591.x
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Effect of growth hormone replacement on bone mass in adults with adult onset growth hormone deficiency.
    • Authors: Holmes SJ, Whitehouse RW, Swindell R, Economou G, Adams JE, Shalet SM
    • Issue date: 1995 Jun
    • Long-term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or long-term GH replacement therapy.
    • Authors: Rahim A, Holmes SJ, Adams JE, Shalet SM
    • Issue date: 1998 Apr
    • Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency.
    • Authors: O'Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE, Shalet SM
    • Issue date: 1993 May
    • Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset.
    • Authors: Kaufman JM, Taelman P, Vermeulen A, Vandeweghe M
    • Issue date: 1992 Jan
    • Combined treatment of growth hormone and the bisphosphonate pamidronate, versus treatment with GH alone, in GH-deficient adults: the effects on renal phosphate handling, bone turnover and bone mineral mass.
    • Authors: Valk NK, Erdtsieck RJ, Algra D, Lamberts SW, Pols HA
    • Issue date: 1995 Sep
    DSpace software (copyright © 2002 - 2021)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.